These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 30595025

  • 1. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
    Yiu Y, Fayson S, Smith H, Matrka L.
    Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
    [Abstract] [Full Text] [Related]

  • 2. The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis.
    Ponduri A, Azmy MC, Axler E, Lin J, Schwartz R, Chirilă M, Dikkers FG, Yang CJ, Mehta V, Gangar M.
    Laryngoscope; 2023 Sep; 133(9):2046-2054. PubMed ID: 36651338
    [Abstract] [Full Text] [Related]

  • 3. Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis.
    Tjon Pian Gi RE, San Giorgi MR, Pawlita M, Michel A, van Hemel BM, Schuuring EM, van den Heuvel ER, van der Laan BF, Dikkers FG.
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3231-6. PubMed ID: 27188508
    [Abstract] [Full Text] [Related]

  • 4. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
    Matsuzaki H, Makiyama K, Hirai R, Suzuki H, Asai R, Oshima T.
    Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant Human Papillomavirus Vaccination in Recurrent Respiratory Papilloma Patients Older than 45.
    Ivancic R, Freeman T, de Silva B, Forrest A, Kim B, Matrka L.
    Laryngoscope; 2024 Jul; 134(7):3226-3229. PubMed ID: 38401115
    [Abstract] [Full Text] [Related]

  • 6. The use of the quadrivalent human papillomavirus vaccine (gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma.
    Young DL, Moore MM, Halstead LA.
    J Voice; 2015 Mar; 29(2):223-9. PubMed ID: 25619468
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic use of the HPV vaccine in Recurrent Respiratory Papillomatosis: A case report.
    Sullivan C, Curtis S, Mouzakes J.
    Int J Pediatr Otorhinolaryngol; 2017 Feb; 93():103-106. PubMed ID: 28109479
    [Abstract] [Full Text] [Related]

  • 8. Intersurgical interval increased with use of quadrivalent human papillomavirus vaccine (Gardasil) in a pediatric patient with recurrent respiratory papillomatosis: A case report.
    Baumanis MM, Elmaraghy CA.
    Int J Pediatr Otorhinolaryngol; 2016 Dec; 91():166-169. PubMed ID: 27863633
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human Papillomavirus Vaccination as an Adjuvant Therapy for Recurrent Respiratory Papillomatosis: Additional Case Series.
    Matsuzaki H, Makiyama K, Hasegawa H, Asai R, Morita M, Oshima T.
    J Voice; 2024 Jan; 38(1):204-209. PubMed ID: 34600799
    [Abstract] [Full Text] [Related]

  • 11. Update on Recurrent Respiratory Papillomatosis.
    Derkay CS, Bluher AE.
    Otolaryngol Clin North Am; 2019 Aug; 52(4):669-679. PubMed ID: 31078306
    [Abstract] [Full Text] [Related]

  • 12. Treatment outcomes of recurrent respiratory papillomatosis : Retrospective analysis of juvenile and adult cases.
    Papaioannou VA, Lux A, Voigt-Zimmermann S, Arens C.
    HNO; 2018 Jan; 66(Suppl 1):7-15. PubMed ID: 28840259
    [Abstract] [Full Text] [Related]

  • 13. Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.
    Nyirjesy S, Osmundson P, Matrka L.
    J Voice; 2022 Jul; 36(4):587.e21-587.e25. PubMed ID: 32891477
    [Abstract] [Full Text] [Related]

  • 14. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
    Smahelova J, Hamsikova E, Ludvikova V, Vydrova J, Traboulsi J, Vencalek O, Lukeš P, Tachezy R.
    JAMA Otolaryngol Head Neck Surg; 2022 Jul 01; 148(7):654-661. PubMed ID: 35653138
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of the human papillomavirus (types 6, 11, 16, and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis.
    Hermann JS, Weckx LY, Monteiro Nürmberger J, Santos Junior GF, Campos Pignatari AC, Nagata Pignatari SS.
    Int J Pediatr Otorhinolaryngol; 2016 Apr 01; 83():94-8. PubMed ID: 26968061
    [Abstract] [Full Text] [Related]

  • 16. Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men Second Report: Negative Conversion of HPV in Laryngeal Secretions.
    Hirai R, Makiyama K, Matsuzaki H, Oshima T.
    J Voice; 2018 Jul 01; 32(4):488-491. PubMed ID: 28866231
    [Abstract] [Full Text] [Related]

  • 17. [Recurrent respiratory papillomatosis: indication for HPV vaccination?].
    Pawlita M, Gissmann L.
    Dtsch Med Wochenschr; 2009 Apr 01; 134 Suppl 2():S100-2. PubMed ID: 19353471
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis.
    Hočevar-Boltežar I, Matičič M, Sereg-Bahar M, Gale N, Poljak M, Kocjan B, Zargi M.
    Eur Arch Otorhinolaryngol; 2014 Dec 01; 271(12):3255-62. PubMed ID: 24964770
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.